Our lab has focused on apoB mRNA editing as a model of post- transcriptional base modification in humans. ApoB mRNA editing is a site specific deamination of a cytidine residue to a uridine at nucleotide position 6666 in the ApoB mRNA transcript. The deaminination reaction is a zinc dependent process mediated by a cytadine deaminase referred to as apolipoprotein B editing component 1 (APOBEC-1), RNA editing activity of APOBEC-1 is trictly dependent on assembly on an enzyme complex that includes APOBEC-1(the catalytic subunit), and auxiliary proteins. During the past year, we have examined regulation of apoB mRNA editing by analysis of post-transcriptional proetin phosphorylation.

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BM006005-04
Application #
6161312
Study Section
Special Emphasis Panel (LMTB)
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost